Venous Thromboembolic Disease in Colorectal Patients

ABSTRACT

Venous thromboembolic disease, which includes deep vein thromboses as well as pulmonary emboli, can be a significant complication in the postoperative patient. In particular, colorectal patients often carry a higher risk for venous thromboembolism when compared with patients undergoing other operative procedures. Features unique to colorectal patients are the high incidence of inflammatory bowel disease or malignancy. Typically, these patients will undergo lengthy pelvic procedures, which also contribute to a cumulative risk of venous thrombosis. It is critical that all patients and the proposed operative procedure are appropriately risk stratified. Risk stratification allows for easier implementation of an appropriate prophylactic strategy. There are a wide range of safe and effective mechanical and pharmacologic measures available. The authors provide very specific recommendations, but note that clinical judgment plays a significant role.

KEYWORDS

Deep vein thrombosis - pulmonary embolism - prophylaxis - venous thromboembolism - colorectal surgery

REFERENCES

• 1 Horlander K T, Mannino D M, Leeper K V. Pulmonary embolism mortality in the United States, 1979–1998: an analysis using multiple-cause mortality data.  Arch Intern Med. 2003;  163 1711-1717
• 2 Anderson Jr F A, Wheeler H B, Goldberg R J et al.. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.  Arch Intern Med. 1991;  151(5) 933-938
• 3 Silverstein M D, Heit J A, Mohr D N, Petterson T M, O'Fallon W M, Melton III L J. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.  Arch Intern Med. 1998;  158(6) 585-593
• 4 Sandler D A, Martin J F. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?.  J R Soc Med. 1989;  82 203-205
• 5 Seddighzadeh A, Zurawska U, Shetty R, Goldhaber S Z. Venous thromboembolism in patients undergoing surgery: low rates of prophylaxis and high rates of filter insertion.  Thromb Haemost. 2007;  98(6) 1220-1225
• 6 Yu H T, Dylan M L, Lin J et al.. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism.  Am J Health Syst Pharm. 2007;  64 69-76
• 7 Virchow R LK. Translation in Matzdorff AC, Bell WR, trans Thrombosis and embolie (1846–1856). Canton, MA; Science History Publications 1998 Originally published in German as “Thrombose und Embolie. Gefässentzündung und septische Infektion,” Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Frankfurt am Main: Von Meidinger & Sohn; 1856:219–732
• 8 Anning S T. The historical aspects of venous thrombosis.  Med Hist. 1957;  1 28-37
• 9 Kikura M, Takada T, Sato S. Age- and sex-specific incidence, risk, and latency period of a perioperative acute thromboembolism syndrome (PATS).  Thromb Haemost. 2004;  91 725-732
• 10 Geerts W H, Graham F P, Heit J A et al.. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.  Chest. 2004;  126 338S-400S
• 11 Geerts W H, Heit J A, Clagett G P, Pineo G F, Colwell C W, Anderson F A, Wheeler B. Prevention of venous thromboembolism.  Chest. 2001;  119 132S-175S
• 12 Iversen L H, Thorlacius-Ussing O. Relationship of coagulation test abnormalities to tomour burden and postoperative DVT in resected colorectal cancer.  Thromb Haemost. 2002;  87 402-408
• 13 Stender M T, Nielsen T S, Frøkjaer J B, Larsen T B, Lundbye-Christensen S, Thorlacius-Ussing O. High preoperative prevalence of deep venous thrombosis in patients with colorectal cancer.  Br J Surg. 2007;  94(9) 1100-1103
• 14 Bernstein C N, Blanchard J F, Houston D S et al.. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study.  Thromb Haemost. 2001;  85 430-434
• 15 Solem C A, Loftus E V, Tremaine W J, Sandborn W J. Venous thromboembolism in inflammatory bowel disease.  American Journal of Gastroenterology. 2004;  99(1) 97-101
• 16 Anderson F A, Spencer F A. Risk factors for venous thromboembolism.  Circulation. 2003;  107(Suppl 1) I9-I16
• 17 Nguyen N T, Cronan M, Braley S, Rivers R, Wolfe B M. Duplex ultrasound assessment of femoral venous flow during laparoscopic and open gastric bypass.  Surg Endosc. 2003;  17(2) 285-290
• 18 Lindberg F, Bergqvist D, Rasmussen I. Incidence of thromboembolic complications after laparoscopic cholecystectomy: review of the literature.  Surg Laparosc Endosc. 1997;  7 324-331
• 19 Benko T, Cooke E A, McNally M A, Mollan R AB. Graduated compression stockings: knee length or thigh length.  Clin Orthop Relat Res. 2001;  383 197-203
• 20 Amaragiri S V, Lees T A. Elastic compression stockings for prevention of deep vein thrombosis.  Cochrane Database Sys Rev. 2008;  (1) , CD001484
• 21 Prins M H, Hirsh J. A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism.  Arch Intern Med. 1991;  151 1721-1731
• 22 Ginzburg E, Cohn S M, Lopez J, Jackowski J, Brown M, Hameed S M. Miami Deep Vein Thrombosis Study Group . Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma.  Br J Surg. 2003;  90(11) 1338-1344
• 23 Geerts W H, Berqvist D, Pineo G F et al.. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.)  Chest. 2008;  133(suppl) 381s-453s
• 24 Collins R, Scrimgeor A, Yusuf S. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery.  N Engl J Med. 1988;  318 1162-1173
• 25 Clagett G P, Reisch J S. Prevention of venous thromboembolism in general surgical patients: results of meta-analysis.  Ann Surg. 1988;  208 227-240
• 26 Mismetti P, Laporte S, Darmon J Y et al.. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.  Br J Surg. 2001;  88 913-930
• 27 Wille-Jorgensen P, Rasmussen M D, Anderson B R et al.. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery.  Cochrane Database Syst Rev. 2004;  (1) , CD001217
• 28 Kakkar V V, Cohen A T, Edmonson R A et al.. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery.  Lancet. 1993;  341 259-265
• 29 Nurmohamed M T, Verhaeghe R, Haas S et al.. A comparative trial of low molecular weight heparin(enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery.  Am J Surg. 1995;  169 567-571
• 30 Bergqvist D, Matzsch T, Burmark U S et al.. Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis.  Br J Surg. 1988;  75 888-891
• 31 McLeod R S, Geerts W H, Sniderman K W et al.. Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian Colorectal DVT Prophylaxis Trial: a randomized, double-blind trial.  Ann Surg. 2001;  233 438-444
• 32 Koch A, Bouges S, Ziegler S et al.. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analysis.  Br J Surg. 1997;  84 750-759
• 33 King D J, Kelton J G. Heparin-associated thrombocytopenia.  Ann Intern Med. 1984;  100 535-540
• 34 Kelton J G, Sheridan D, Santos A et al.. Heparin-induced thrombocytopenia: laboratory studies.  Blood. 1988;  72 925-930
• 35 Warkentin T E, Levine M N, Hirsh J et al.. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.  N Engl J Med. 1995;  332 1330-1335
• 36 Martel N, Lee J, Wells P. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylasxis: a meta-analysis.  Blood. 2005;  106 2710-2715
• 37 Samama M M, Gerotziafas G T. Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide(fondaparinux).  Thromb Res. 2003;  109 1-11
• 38 Eriksson B I, Bauer K A, Lassen M R, Turpie A GG. for the Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study . Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.  N Engl J Med. 2001;  345 1298-1304
• 39 Lassen M R, Bauer K A, Eriksson B I, Turpie A GG. for the European Pentasaccharide Hip Elective Surgery Study (EPHESUS) Steering Committee . Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.  Lancet. 2002;  359 1715-1720
• 40 Turpie A GG, Bauer K A, Eriksson B I, Lassen M R. for the Steering Committees of the Pentasaccharide Orthopedic Prophylaxis Studies . Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.  Arch Intern Med. 2002;  162 1833-1840
• 41 Agnelli G, Bergqvist D, Cohen A T, Gallus A S, Gent M. and PEGASUS Investigators . Randomised clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.  Br J Surg. 2005;  92 1212-1220
• 42 Turpie A G, Bauer K A, Caprini J A, Comp P C, Gent M, Muntz J E. Apollo investigators . Fondaparinox combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized double-blind comparison.  J Thromb Haemost. 2007;  5 1854-1861
• 43 Huber O, Bounameaux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge. An underestimated risk.  Arch Surg. 1992;  127 310-313
• 44 Lausen I, Jensen R, Jorgensen L N et al.. Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomized controlled study of prolonged thromboprophylaxis.  Eur J Surg. 1998;  164 657-663
• 45 Bergqvist D, Angelli G, Cohen A et al.. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.  N Engl J Med. 2002;  346 975-980
• 46 Rasmussen M S, Jorgensen L N, Wille-Jorgensen P et al.. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter open-label study.  J Thromb Haemost. 2006;  4 2384-2390
• 47 National Institute for Health and Clinical Excellence .Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing sugery. NICE clinical guideline No. 46:1–160. Available at: http://www.nice.org.uk/CG046 Accessed September 28, 2008